Compare CLLS & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLLS | WRN |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | France | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.5M | 676.9M |
| IPO Year | 2007 | N/A |
| Metric | CLLS | WRN |
|---|---|---|
| Price | $4.09 | $3.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $8.50 | $4.88 |
| AVG Volume (30 Days) | 81.2K | ★ 1.4M |
| Earning Date | 11-07-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,551,000.00 | N/A |
| Revenue This Year | $32.58 | N/A |
| Revenue Next Year | $20.68 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.04 | N/A |
| 52 Week Low | $1.10 | $0.90 |
| 52 Week High | $5.48 | $3.53 |
| Indicator | CLLS | WRN |
|---|---|---|
| Relative Strength Index (RSI) | 39.38 | 65.34 |
| Support Level | $3.99 | $3.29 |
| Resistance Level | $4.32 | $3.53 |
| Average True Range (ATR) | 0.25 | 0.18 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 11.97 | 76.50 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).